As ESG moves from buzzword to benchmark, Zagga’s commitment to the UN’s Principles for Responsible Investment shows how ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced financial results for its third quarter ended September 30, 2025 and reaffirmed ...